Sign Out
Fertility: There are no clinical studies on the effect of nadroparin on fertility.
Pregnancy: Studies in animals have not shown any teratogenic or foetotoxic effects. However, there is only limited clinical data concerning transplacental passage of nadroparin in pregnant women. Therefore, the use of nadroparin during pregnancy is not advised, unless the therapeutic benefits outweigh the possible risks.
Breastfeeding: There is limited information on the excretion of nadroparin in breast milk. Therefore, the use of nadroparin during breastfeeding is not advised.
